Oxygen concentrating apparatus
Latest Teijin Pharma Limited Patents:
- Anti-IGF-I receptor humanized antibody
- MENTAL DISORDER DETERMINATION DEVICE, TERMINAL DEVICE, CLASSIFIER, MENTAL DISORDER DETERMINATION ASSISTANCE METHOD, AND RECORDING MEDIUM
- Phototherapy device
- Oxygen supply device and method for controlling same
- OXYGEN ENRICHMENT DEVICE, CONTROL METHOD AND CONTROL PROGRAM
Description
The broken lines in
Claims
The ornamental design for an oxygen concentrating apparatus, as shown and described.
Referenced Cited
U.S. Patent Documents
Foreign Patent Documents
Other references
D437056 | January 30, 2001 | Remes et al. |
D471982 | March 18, 2003 | Cheng |
D490155 | May 18, 2004 | Nakamura |
D510437 | October 4, 2005 | Lang et al. |
D513074 | December 20, 2005 | Nakamura et al. |
D528212 | September 12, 2006 | Conway et al. |
D550360 | September 4, 2007 | McCombs et al. |
D585540 | January 27, 2009 | Lithgow et al. |
1154513 | September 2002 | JP |
1154786 | September 2002 | JP |
1167851 | March 2003 | JP |
1349622 | January 2009 | JP |
- Teijin Human Chemistry, Human Solutions; Leaflet concerning Hi-sanso® 3R; Oct. 8, 2008; pp. 1-3.
- Information taken from the Teijin-pharma website concerning Hi-sanso® 3R; Oct. 8, 2008.
Patent History
Patent number: D604417
Type: Grant
Filed: Dec 12, 2008
Date of Patent: Nov 17, 2009
Assignee: Teijin Pharma Limited (Tokyo)
Inventors: Katsushi Fujimoto (Iwakuni), Hiroki Takeshima (Iwakuni)
Primary Examiner: T. Chase Nelson
Assistant Examiner: Anhdao Doan
Attorney: Sughrue Mion, PLLC
Application Number: 29/329,318
Type: Grant
Filed: Dec 12, 2008
Date of Patent: Nov 17, 2009
Assignee: Teijin Pharma Limited (Tokyo)
Inventors: Katsushi Fujimoto (Iwakuni), Hiroki Takeshima (Iwakuni)
Primary Examiner: T. Chase Nelson
Assistant Examiner: Anhdao Doan
Attorney: Sughrue Mion, PLLC
Application Number: 29/329,318
Classifications
Current U.S. Class:
Pulmonary (38) (D24/164)